Cardiff Oncology Inc (CRDF) — Tangible Net Worth Ratio
Cardiff Oncology Inc (CRDF) has a Tangible Net Worth Ratio of 100.0% as of December 2025. This metric is calculated by deducting intangible assets ($0.00) from net assets ($45.39 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Cardiff Oncology Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Cardiff Oncology Inc Tangible Net Worth Ratio (2012–2025)
This chart shows how Cardiff Oncology Inc's Tangible Net Worth Ratio has changed across 14 annual periods from 2012 to 2025. As of December 2025, the ratio stands at 100.0%, reflecting net assets of $45.39 Million with intangible assets of $0.00 USD. See CRDF days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Cardiff Oncology Inc (2012–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Cardiff Oncology Inc from 2012 to 2025, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Cardiff Oncology Inc stock valuation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $45.39 Million | $0.00 | $61.88 Million | ▲ +0.0 pp |
| 2024 | 100.0% | $82.95 Million | $0.00 | $97.19 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $69.74 Million | $0.00 | $81.64 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $106.34 Million | $0.00 | $116.19 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $140.42 Million | $0.00 | $149.54 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $128.16 Million | $0.00 | $134.73 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $7.31 Million | $0.00 | $13.09 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $10.08 Million | $0.00 | $14.17 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $6.51 Million | $0.00 | $12.29 Million | ▲ +0.0 pp |
| 2016 | 100.0% | $19.77 Million | $0.00 | $43.95 Million | ▲ +0.0 pp |
| 2015 | 100.0% | $48.70 Million | $0.00 | $71.45 Million | ▲ +0.0 pp |
| 2014 | 100.0% | $8.35 Million | $0.00 | $28.90 Million | ▲ +0.0 pp |
| 2013 | 100.0% | $20.39 Million | $0.00 | $27.16 Million | ▲ +0.0 pp |
| 2012 | 100.0% | $2.17 Million | $0.00 | $11.66 Million | — |